ARDT
Ardent Health Partners, LLC·Healthcare
9.40
1.364%(−0.13)
Market ClosedLast Updated: — ET
52W L: $8.0752W H: $15.48
ARDT NEWS
defenseworld.net
Apr 4
JPMorgan Chase & Co. Has $3.75 Million Stake in Ardent Health, Inc. $ARDT
JPMorgan Chase and Co. lowered its position in shares of Ardent Health, Inc. (NYSE: ARDT) by 17.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 283,061 shares of the company's stock after selling 59,738 shares during the quarter. JPMorgan Chase and Co.
defenseworld.net
Apr 4
Ardent Health, Inc. (NYSE:ARDT) Given Average Rating of “Hold” by Brokerages
Ardent Health, Inc. (NYSE: ARDT - Get Free Report) has been assigned an average recommendation of "Hold" from the fourteen research firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company.
prnewswire.com
Mar 18
Kuehn Law Encourages Investors of Ardent Health, Inc. to Contact Law Firm
NEW YORK, March 18, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Ardent Health, Inc. (NYSE: ARDT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Ardent Health caused the company to misrepresent or fail to disclose that: (1) Ardent Health did not primarily rely on "detailed reviews of historical collections" in determining collectability of accounts receivable nor did "management determine[] [when an] account is uncollectible"; (2) the Company's accounts receivable framework "utilized a 180-day cliff at which time an account became fully reserved," allowed Ardent Health to report higher amounts of accounts receivable and delay recognizing losses on uncollectable accounts; and (3) Ardent Health did not even maintain professional malpractice liability insurance in amounts "sufficient to cover claims arising out of [its] operations[.
defenseworld.net
Mar 10
Ardent Health, Inc. (NYSE:ARDT) Receives Average Rating of “Hold” from Analysts
Shares of Ardent Health, Inc. (NYSE: ARDT - Get Free Report) have received an average rating of "Hold" from the thirteen research firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and seven have issued a buy recommendation on
globenewswire.com
Mar 9
Levi & Korsinsky Notifies Ardent Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ARDT
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025.
businesswire.com
Mar 9
ARDT CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Ardent Investors of the Securities Class Action Lawsuit Deadline on March 9, 2026
NEW YORK--(BUSINESS WIRE)---- $ARDT #ARDT--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has.
